Johnathan Winstead, MD
Otolaryngology · Johnson City, TNNPI 1124204698
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.8%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Intuitive Surgical at 43.2% of the total. Reporting peaked in 2022 at $2,437 and has fallen 83.9% since, to $392 in 2025.
Across 98 payments — averaging $46.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Inspire Medical Systems, Inc.$749
- Sanofi$538
- Regeneron Healthcare Solutions, Inc.$377
- GSK$276
- Stryker$212
- plus $450 from 13 others
What the payments were for
- Travel & lodging$1,17726%
- Food & beverage$2,55556%
- Education$84819%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $1,978 |
| Inspire Medical Systems, Inc. | 11 | $749 |
| Sanofi | 27 | $538 |
| Regeneron Healthcare Solutions, Inc. | 15 | $377 |
| GSK | 14 | $276 |
| Stryker | 4 | $212 |
| AstraZeneca | 1 | $123 |
| Novartis | 4 | $57 |
| Advanced Bionics, LLC | 2 | $49 |
| Smith+Nephew | 2 | $37 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Intersect ENT, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Cochlear Americas | 1 | $21 |
| Aerin Medical Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Resmed Corp | 1 | $18 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,580 in reported general payments places this provider in the 80th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 26 | $2,937 |
| Cefdinir | 52 | $1,548 |
| Clonazepam | 27 | $1,110 |
| Ofloxacin | 20 | $899 |
| Ipratropium Bromide | 34 | $827 |
| Fluticasone Propionate | 30 | $585 |
| Methylprednisolone | 53 | $398 |
| Ondansetron OdtOndansetron | 48 | $371 |
| Levothyroxine Sodium | 62 | $368 |
| Omeprazole | 18 | $324 |
| Triamcinolone Acetonide | 11 | $296 |
| Mupirocin | 33 | $291 |
| Clindamycin Hcl | 24 | $289 |
| Montelukast Sodium | 28 | $259 |
| Oxycodone Hcl | 63 | $259 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Johnson City
- Timothy ZajoncJohnson City$4K
- Bruce AbkesJohnson City$3K
- Rakesh ChandraNashville$381K
- David FortuneHermitage$298K
- Grady BryantHermitage$74K
- Marion GillespieMemphis$67K
- Clyde MathisonFarragut$66K
- Dean KlugGermantown$37K
- Michael TopfNashville$36K
- John GleysteenMemphis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.